ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,342
Diagnostic referrals
1,012
Outstanding pathways
298

Screening pathway

  1. Screening5,342Encounters
  2. Positive finding1,866Documented findings
  3. Referral1,012Diagnostic referrals
  4. Follow-up1,269Diagnostic visits
  5. Outcome714Resolved pathways

Stage totals use different units. Pending pathways: 298. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2027-05-11, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4920 · Expanded synthetic participant 4920Site A — Urban Referral Hub
EXP-4921 · Expanded synthetic participant 4921Site D — Community Engagement Programme
EXP-4922 · Expanded synthetic participant 4922Site E — Resource-Constrained Navigation Programme
EXP-4923 · Expanded synthetic participant 4923Site C — Rural Outreach Programme
EXP-4924 · Expanded synthetic participant 4924Site A — Urban Referral Hub
EXP-4925 · Expanded synthetic participant 4925Site C — Rural Outreach Programme
EXP-4926 · Expanded synthetic participant 4926Site E — Resource-Constrained Navigation Programme
EXP-4927 · Expanded synthetic participant 4927Site D — Community Engagement Programme
EXP-4928 · Expanded synthetic participant 4928Site C — Rural Outreach Programme
EXP-4929 · Expanded synthetic participant 4929Site D — Community Engagement Programme
EXP-4930 · Expanded synthetic participant 4930Site B — Peri-Urban Access Programme
EXP-4931 · Expanded synthetic participant 4931Site C — Rural Outreach Programme
EXP-4932 · Expanded synthetic participant 4932Site C — Rural Outreach Programme
EXP-4933 · Expanded synthetic participant 4933Site D — Community Engagement Programme
EXP-4934 · Expanded synthetic participant 4934Site A — Urban Referral Hub
EXP-4935 · Expanded synthetic participant 4935Site D — Community Engagement Programme
EXP-4936 · Expanded synthetic participant 4936Site E — Resource-Constrained Navigation Programme
EXP-4937 · Expanded synthetic participant 4937Site E — Resource-Constrained Navigation Programme
EXP-4938 · Expanded synthetic participant 4938Site C — Rural Outreach Programme
EXP-4939 · Expanded synthetic participant 4939Site D — Community Engagement Programme
EXP-4940 · Expanded synthetic participant 4940Site D — Community Engagement Programme
EXP-4941 · Expanded synthetic participant 4941Site C — Rural Outreach Programme
EXP-4942 · Expanded synthetic participant 4942Site B — Peri-Urban Access Programme
EXP-4944 · Expanded synthetic participant 4944Site D — Community Engagement Programme
EXP-4945 · Expanded synthetic participant 4945Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1963
HPV DNA
2655
Cytology
724

Navigation activity

Barrier documented
922
Contact attempt
1480
Navigation intervention
414
Diagnostic booking
1282
Diagnostic visit
1269

Documented barriers

Contact difficulty
295
Transport difficulty
305
Appointment coordination
322

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.